Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Randomized Study to Compare the Safety, Local Tolerability and Efficacy of a 0.5% Ivermectin Cream Compared to a Topical Vehicle Control in Subjects With Pediculus Humanus Capitis Infestation

NCT00994422 is registered in ClinicalTrials.gov with Topaz Pharmaceuticals Inc as lead sponsor.

NCT NCT00994422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00994422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Randomized Study to Compare the Safety, Local Tolerability and Efficacy of a 0.5% Ivermectin Cream Compared to a Topical Vehicle Control in Subjects With Pediculus Humanus Capitis Infestation
Lead sponsor
Topaz Pharmaceuticals Inc
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
December 31, 2009
Enrollment
264 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

head lice